A comprehensive review of rituximab therapy in rheumatoid arthritis patients

Rituximab (RTX) is an approved treatment for rheumatoid arthritis (RA) patients that do not respond adequately to disease-modifying antirheumatic drugs. However, different new concerns, such as efficacy, optimum dose, safety issues, prediction of response to RTX, and pregnancy outcomes have attracte...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical rheumatology 2019-11, Vol.38 (11), p.2977-2994
Hauptverfasser:	Tavakolpour, Soheil, Alesaeidi, Samira, Darvishi, Mohammad, GhasemiAdl, Mojtaba, Darabi-Monadi, Sahar, Akhlaghdoust, Meisam, Elikaei Behjati, Somayeh, Jafarieh, Arash
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - pharmacology Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy BLyS protein Fc receptors Gastrointestinal diseases Humans Immunotherapy Infections Interleukin 6 Lymphocytes B Medicine Medicine & Public Health Monoclonal antibodies Nervous system Pregnancy Psoriasis Review Article Rheumatoid arthritis Rheumatology Rituximab Rituximab - pharmacology Rituximab - therapeutic use Safety Side effects Teratogenicity Transforming growth factor-b1 Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!